Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (70)

« Back to Publications

Changes in platelet count as a marker of myocardial iron uptake after administration of ferric carboxymaltose in patients with heart failure.

Mollar A. et al, (2026), Sci Rep, 16

Acute Heart Failure in Pregnancy and Postpartum: Role of Iron Deficiency and Anemia in an Indian Multicenter Case–Control Study

Nair M. et al, (2025)

Intravenous iron for the treatment of iron deficiency in adults with cystic fibrosis: a prospective observational cohort study.

Talbot NP. et al, (2025), Eur Respir J, 66

Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy - a hypothesis-generating study.

Nunez J. et al, (2025), Eur J Heart Fail, 27, 2352 - 2356

Iron Deficiency in Cardiovascular Disease　- Diagnosis, Clinical Implications, and Future Directions.

Graham FJ. et al, (2025), Circ J

Tissue-Specific Iron Levels Modulate Lipid Peroxidation and the FLASH Radiotherapy Effect.

Vilaplana-Lopera N. et al, (2025)

Anaemia, neurohormonal activation, and myocardial iron depletion in heart failure: can this vicious circle be broken?

Lakhal-Littleton S., (2025), Eur Heart J, 46, 1524 - 1527

Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm

Vera-Aviles M. et al, (2025)

Baseline ferritin predicts myocardial iron uptake following intravenous iron therapy- a hypothesis generating study

Nunez J. et al, (2025)

Hepcidin and Tissue-Specific Iron Regulatory Networks.

Lakhal-Littleton S. and Peyssonnaux C., (2025), Adv Exp Med Biol, 1480, 89 - 102

Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.

Piechnik SK. et al, (2025), Br J Haematol, 206, 349 - 352

Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway.

Vera-Aviles M. et al, (2024), Eur Heart J, 45, 4497 - 4508

Iron deficiency and supplementation in heart failure.

Lakhal-Littleton S. and Cleland JGF., (2024), Nat Rev Cardiol, 21, 463 - 486

Low Serum Ferritin Might Predict Incident Heart Failure: But Why and Is It Clinically Useful?

Cleland JGF. et al, (2024), JACC Heart Fail, 12, 549 - 551

Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study

Vera-Aviles M. et al, (2024)

Load More

1
2
3
4
5